The number of pending lawsuits in MDL 3094, Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation has been steadily increasing as more people allege injuries such as gastrointestinal disorders, blood clots, and vision loss were caused by their use of Ozempic
Semaglutide has been shown to produce clinically significant weight loss in adults with obesity or overweight when used alongside dietary changes, increased physical activity and behavioural support
In clinical tests, users saw up to 88% reduction in inflammatory acne lesions in just a few weeks
Remove the Needle: After injecting, remove the needle from the skin and dispose of it safely in a sharps container
You still get the flavor and experience without overloading your system
Dehydration related to Ozempic is also often the cause of constipation